Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page shows an updated revision tag, changing from v3.6.3 to v3.6.4, indicating a new site version without altering the study details.
    Difference
    0.0%
    Check dated 2026-07-27T18:00:41.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.6.2 to v3.6.3, indicating a new page revision. This is a minor metadata update that does not alter the study content or data.
    Difference
    0.0%
    Check dated 2026-07-06T05:06:26.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.0 to v3.6.2, indicating a new release of the page's versioning metadata. This change does not affect the visible content or user-facing features.
    Difference
    0.0%
    Check dated 2026-06-28T13:52:45.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added new quick-access sections such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study, and the page revision tag updated to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-14T12:35:35.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    A new page revision, v3.5.5, has been added to replace the previous v3.5.4, indicating a routine update to the page's revision history rather than substantive changes to the trial details.
    Difference
    0.0%
    Check dated 2026-06-07T03:45:55.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Updates add new study contacts and their details (Pere Barba, MD; Federica Cattaneo; Glen Lew as Study Director) and remove older contact Claire Fabre, while indicating site recruitment progression with 'Completed' statuses across locations.
    Difference
    0.7%
    Check dated 2026-05-23T22:36:35.000Z thumbnail image

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.